Santa Cruz Biotechnology offers a broad range of FIV p24 monoclonal antibodies for research in feline immunodeficiency virus (FIV) studies. FIV p24 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FIV p24 protein serves as a core component of the FIV virus, playing a crucial role in viral assembly and immune evasion. Understanding FIV p24 function is essential for developing diagnostic tools and therapeutic strategies against FIV, which poses significant health risks to domestic cats. The study of FIV p24 contributes to broader insights into retroviral biology and pathogenesis. Research focused on FIV p24 has revealed important mechanisms of viral replication and host-pathogen interactions. Investigating FIV p24 dynamics helps scientists better understand viral lifecycle and potential therapeutic targets. Characterization of FIV p24 continues to provide valuable information for developing antiviral strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of FIV and contribute to improved feline health outcomes.